Weely Conference: Insilico Medicine at Ai4 2026: Dr. Alex Zhavoronkov to Deliver Two Keynote Sessions on AI Drug Discovery and Anti-Aging (IMAGE)
Caption
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, will attend the conference and deliver two high-profile sessions—a panel discussion alongside top industry experts on "AI's Race to Reinvent Medicine", and a solo keynote address exploring "How to Address Diseases and Aging Simultaneously Using Frontier AI".
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content